Introduction
Prodrug formation is an important means of enhancing drug efficiency. A major requirement of the prodrug derivative is that it must be converted rapidly, or at a controlled rate, to the active therapeutic agent in vivo while at the same time be sufficiently stable in vitro such that a stable pharmaceutical product may be developed. This is often achieved using the double prodrug concept via molecules that make use of an enzymatic release mechanism followed by a spontaneous chemical reaction [1] .
Another important aspect of prodrug design is the need for the carrier moiety to be nontoxic [2] . To this end, biologically compatible compounds, particularly α-amino acids, have been used as carriers for drugs that contain either the hydroxyl functional group (forming esters) or that contain a carboxyl or amine group (forming amides) [3] . Esters of α-amino acids are chemically very unstable, the ester group being activated towards hydrolysis in acidic and neutral solutions by the strong electron-withdrawing inductive effect of the protonated amino group [4] .
For many years dacarbazine 1 has been one of the most widely used drugs to treat malignant melanoma [5] .
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The biological action of dacarbazine and, in general, the anti-cancer 1-aryl-3,3-dimethyltriazenes (2, in Figure 1 ) is a consequence of their capacity to alkylate DNA [6] .
Figure 1 here
These compounds suffer metabolic oxidation by cytochrome P450 enzymes to give hydroxymethyltriazenes 3, which, by loss of formaldehyde, generate the cytotoxic monomethyltriazenes 4 ( Figure 1 ) [7] [8] [9] . These are known alkylating agents, capable of methylating DNA and RNA [10, 11] . However, dimethyltriazenes are poorly metabolised by humans [12] . Consequently, with the aim of finding suitable prodrugs that by-pass the need for this oxidative metabolism, alongside hydroxymethyltriazenes 3 themselves [13] , a range of derivatives of 3 and 4, including alkyl ether, aryl ether, alkanethioether, and acyl ester derivatives of 3 and acyl, acyloxymethylcarbamate and ureido derivatives of 4, have been synthesised by several groups, including ourselves [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] . Indeed, one such compound, the imidazo[3,4-e]tetrazin-5-one temozolomide 5, [18] has received FDA approval for the treatment of a specific type of brain cancer, anaplastic astrocytoma (http://www.fda.gov/cder/da/da0899.htm).
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Given that the incidence of malignant melanoma is on the increase and is expected to continue to rise [5] there is a need to develop improved pharmacological entities. This, together with the need to employ carrier moieties that are non-toxic, has directed our interests toward triazenes linked to amino acids via the triazene N-3 nitrogen atom and the acyl group of the amino acid [26, 27] . These triazene amide derivatives were found to have reactivities very similar to those of amino acid esters. However, an N-acetylated alanyl derivative displayed significant chemical stability in isotonic phosphate buffer yet rapid hydrolysis to the monomethyltriazene in plasma [27] . To demonstrate the potential of this type of compound as possible bioreversible prodrugs of the anticancer monomethyltriazene system, we here report the synthesis of a series of 3-[α-(acylamino)acyl]-1-aryl-3-methyltriazenes, 6a-l, a determination of their log P values and an examination of their stability both in isotonic pH 7.4 phosphate buffer and in plasma.
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Results and discussion
Synthesis
The α-(acylamino)acyl derivatives, 6a-l, were readily synthesized by conventional coupling reaction of the appropriate 1-aryl-3-methyltriazene 4 with an (S)-N-acylamino acid using dicyclohexylcarbodiimide activation. The 1 H-NMR spectra of 6a-l display a typical triazene N-methyl singlet in the range δ 3.40 to 3.53 p.p.m. For 6d the two methyl groups of the isopropyl side-chain are diastereotopic and appear as two doublets.
Kinetic studies
The hydrolysis of the α-(acylamino)acyltriazenes 6a-l to give the corresponding 3-methyltriazenes 4 ( Figure 1 ) was studied in isotonic phosphate buffer and in 80%
human plasma containing 20% isotonic phosphate buffer. The hydrolysis of 6a was also studied in more detail across the pH range 1-11 in aqueous buffers. Under the reaction conditions the monomethyltriazenes are unstable, hydrolysing further to the corresponding anilines. These reactions were easily followed either by HPLC 
Hydrolysis in aqueous buffers
Half-lives for the hydrolysis of triazenes 6a-l in isotonic phosphate buffer are given in Table 1 . Inspection of Table 1 shows that these compounds decompose at physiological pH with half-lives ranging from 7.6 to 84 h.
Table 1 near here
To better understand the chemistry of these potential prodrug derivatives, compound 6a
was studied in more detail. Pseudo-first-order rate constants, k obs , for its hydrolysis were determined in aqueous buffers (using several buffer concentrations at each pH), in deuterated buffers, and in NaOH and H 2 SO 4 solutions ( Together with the Brønsted plot, these data imply that, in contrast to hydroxide ion, the buffer materials exert catalysis by acting as general bases rather than nucleophiles. This was corroborated by the deuterium isotope effect for the buffer catalysed process, which was determined for pyridine, a relatively weak catalyst, and piperidine, a relatively efficient catalyst. The data are contained in Table 3 ; that the rates are more rapid in H 2 O compared to D 2 O identifies proton transfer from water to the base catalyst as being integral to the rate-limiting hydrolytic step. Table 3 here Thus, taken together these studies reveal that in solutions at a physiological pH of 7.4 the hydrolysis of aminoacyltriazenes comprises three components: pH-independent, base-catalysed and buffer-catalysed reactions. Consequently, general conclusions about the factors affecting the relative magnitudes of the t 1/2 values for the compounds in Table 1 ought to be made with caution, although in pH 7.4 phosphate buffer the major reaction is the hydroxide ion catalysed process. Nevertheless, certain features are apparent. First, compounds 6 a,h-l reveal that the reaction is influenced by the substituent, -X, present in the aryl group, electron-attracting substituents increasing the rate of hydrolysis (these compounds afford a Hammett correlation with a ρ value of +0.81; r 2 =0.99; n=6). Second, the structure of the α-amino acid unit is also important, the glycine derivative 6b being the most reactive and the sterically hindered valine derivative 6d the most stable. Third, the structure of the N-acyl group (compounds 6a,eg) has only a small effect on the rate of hydrolysis.
Hydrolysis in human plasma
Blood serum and plasma are known to contain a range of enzymes that catalyse the hydrolysis of esters and amides [30] . Consequently, we were particularly interested in examining the hydrolysis of the α-(acylamino)acyltriazenes 6a-l in human plasma. The results in Table 1 clearly show that, in plasma, all the compounds studied liberate the corresponding monomethyltriazenes; that they do so at rates that are 3-15 times faster than in phosphate buffer also implies that the α-(acylamino)acyltriazenes are substrates for plasma enzymes. This is in contradistinction to the more reactive parent aminoacyltriazenes, which were found not to be substrates for plasma enzymes [26] .
Although the prodrugs liberate the cytotoxic monomethyltriazene more rapidly in plasma than in phosphate buffer, Figure 5 reveals a correlation (albeit with an r 2 correlation coefficient of 0.67) between the half-lives for the two processes. The implication is that similar electronic and steric effects operate in both cases.
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We observed previously that, despite formally being amide derivatives, 3-acyltriazenes have a reactivity similar to that of esters [15, 21] . Since substrate lipophilicity is one of the main features that influence esterase activity, lower enzyme reactivity being associated with increasing lipophilicity [31] , we examined the effect of substrate lipophilicity on the rate of monomethyltriazene liberation from the prodrugs 6a-l. The partition coefficients between octanol and pH 7.4 phosphate buffer at 25º C for compounds 6a-l (Table 1) give values of log P that cover a wide range of lipophilicities (0.69-3.04). However, Figure 6 reveals no correlation between lipophilicity and plasma stability and we infer that prodrug stability depends only on those factors that govern the chemical reactivity of the aminoacyltriazene unit. acid hydrolysis co-product -point to reaction proceeding via hydrolysis of the triazene amide ( Figure 7 ) and therefore that the α-(acylamino)acyl derivatives provide a potencial prodrug system for the anticancer monomethyltriazenes. The compounds are suitably stable in phosphate buffer (t ½ ca. 8-84h) while, in plasma, those containing an electron withdrawing group in the triazene moiety together with a non-bulky group (acylamino)acyl moiety decompose over 1-2 h. By way of comparison, temozolomide, the recently introduced clinically approved triazene, is likewise a chemically-activated prodrug that has a half-life in both pH 7.4 phosphate buffer and plasma of ca. 2h [32] .
Thus, the acylation of the α -amino group seems to be an effective means of reducing the chemical reactivity of the α-aminoacyl derivatives while retaining a rapid rate of enzymatic hydrolysis. Usually this kind of tuneable dual reactivity is only achieved using the double prodrug strategy [33] , but that involves formaldehyde liberation over which there toxicity concerns [34] [35] [36] . Additionally, these α-(acylamino)acyl derivatives display log P values that suggest they should be well absorbed by biological membranes. 
3-(2-(Acetylamino)propanoyl)-1-(4-cyanophenyl)-3-methyltriazene (6a)
3-(2-(Acetylamino)acetyl)-1-(4-cyanophenyl)-3-methyltriazene (6b)
Yield
3-(2-(Acetylamino)-3-phenylpropanoyl)-1-(4-cyanophenyl)-3-methyltriazene
3-(2-(Acetylamino)-3-methylbutanoyl)-1-(4-cyanophenyl)-3-methyltriazene (6d)
1-(4-Cyanophenyl)-3-methyl-3-(2-(propanoylamino)propanoyl)triazene (6e)
3-(2-(Butanoylamino)propanoyl)-1-(4-cyanophenyl)-3-methyltriazene (6f)
3-(2-(Acetylamino)propanoyl)-1-(4-acetylphenyl)-3-methyltriazene (6h)
3-(2-(Acetylamino)propanoyl)-1-(4-ethoxycarbonylphenyl)-3-methyltriazene (6i)
3-(2-(Acetylamino)propanoyl)-1-(4-bromophenyl)-3-methyltriazene (6k)
3-(2-(Acetylamino)propanoyl)-1-(4-tolyl)-3-methyltriazene (6l)
Experimental procedure for Partition Coefficients
For compounds 6a-l, partition coefficients were determined in octanol-pH 7.4 phosphate buffer at 25 °C. Each phase was mutually saturated before the experiment.
The compounds were dissolved in octanol and the octanol-pH 7.4 mixtures were shaken for 30 min to reach an equilibrium distribution; each phase was analysed separately by the HPLC method described above. The partition coefficients, P exp , were obtained from the ratio of the peak area in octanol to the peak area in buffer. 
